OFIX Orthofix Medical Inc
- Stocks
- Healthcare
- NASDAQ: OFIX
Price (delayed)
$13.8
Market cap
$545.02M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.17
Enterprise value
$651.62M
Orthofix Medical Inc. is a global medical device and biologics company with a spine and extremities focus. The Company's mission is to deliver innovative, quality-driven solutions as it partners with
Highlights
Orthofix Medical's quick ratio has increased by 35% YoY
The EPS has grown by 14% from the previous quarter
The net income has grown by 14% from the previous quarter but it has contracted by 2.7% YoY
Orthofix Medical's debt has increased by 28% YoY
The equity has contracted by 16% YoY
Key stats
What are the main financial stats of OFIX
Market
Valuations
Earnings
Shares outstanding
39.49M
Market cap
$545.02M
Enterprise value
$651.62M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.18
Price to sales (P/S)
0.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.81
Revenue
$809.03M
Gross profit
$545.05M
Operating income
-$95.25M
Net income
-$123.71M
EBIT
-$94.12M
EBITDA
-$11.65M
Free cash flow
$461,000
Per share
Balance sheet
Liquidity
EPS
-$3.17
EPS diluted
-$3.17
Free cash flow per share
$0.01
Book value per share
$11.7
Revenue per share
$20.48
TBVPS
$14.26
Total assets
$837.16M
Total liabilities
$378.81M
Debt
$175.29M
Equity
$458.35M
Working capital
$247.45M
Debt to equity
0.38
Current ratio
2.67
Quick ratio
1.34
Net debt/EBITDA
-9.15
Margins
Efficiency
Dividend
EBITDA margin
-1.4%
Gross margin
67.4%
Net margin
-15.3%
Operating margin
-11.8%
Return on assets
-14.5%
Return on equity
-25.4%
Return on invested capital
-18.2%
Return on capital employed
-13.7%
Return on sales
-11.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OFIX stock price
How has the Orthofix Medical stock price performed over time
Intraday
-2.13%
1 week
8.66%
1 month
25.68%
1 year
-11.82%
YTD
-20.96%
QTD
23.77%
Financial performance
How have Orthofix Medical's revenue and profit performed over time
Revenue
$809.03M
Gross profit
$545.05M
Operating income
-$95.25M
Net income
-$123.71M
Gross margin
67.4%
Net margin
-15.3%
The net income has grown by 14% from the previous quarter but it has contracted by 2.7% YoY
Orthofix Medical's net margin has increased by 14% from the previous quarter
The company's operating income rose by 9% QoQ
The company's operating margin rose by 9% QoQ and by 6% YoY
Price vs fundamentals
How does OFIX's price correlate with its fundamentals
Growth
What is Orthofix Medical's growth rate over time
Valuation
What is Orthofix Medical stock price valuation
P/E
N/A
P/B
1.18
P/S
0.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.81
The EPS has grown by 14% from the previous quarter
The equity has contracted by 16% YoY
The stock's price to book (P/B) is 14% less than its 5-year quarterly average of 1.4
The price to sales (P/S) is 37% lower than the 5-year quarterly average of 1.1
The revenue is up by 4.8% year-on-year
Efficiency
How efficient is Orthofix Medical business performance
OFIX's ROE is down by 23% YoY but it is up by 10% QoQ
The ROS has grown by 16% from the previous quarter and by 13% YoY
The ROIC has grown by 15% from the previous quarter and by 7% YoY
OFIX's return on assets is up by 12% since the previous quarter but it is down by 9% year-on-year
Dividends
What is OFIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OFIX.
Financial health
How did Orthofix Medical financials performed over time
The total assets is 121% greater than the total liabilities
Orthofix Medical's quick ratio has increased by 35% YoY
The company's total liabilities rose by 13% YoY and by 3.8% QoQ
Orthofix Medical's debt is 62% less than its equity
OFIX's debt to equity has soared by 52% YoY
Orthofix Medical's debt has increased by 28% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.